Search for the latest oncology news by tumour type
ASCO 2025: Pembrolizumab gives head and neck cancer patients extra years disease-free
An immunotherapy helps patients live years longer without their cancer getting worse or coming back,…
Search for the latest oncology news by tumour type
An immunotherapy helps patients live years longer without their cancer getting worse or coming back,…
Results from the international phase 3 NIVOPOSTOP clinical trial found that adding nivolumab to chemoradiotherapy…
In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC),…
Patients with advanced gastric or gastro-oesophageal junction (GEJ) cancer treated with CAR T-cell therapy lived…
Results from a multinational study found that using artificial intelligence (AI) assistance can help pathologists…
The international phase 3 DESTINY-Gastric04 clinical trial found that second-line treatment with trastuzumab deruxtecan can help…
Scientists investigating the impact of climate change on women’s health have found that increased heat…
Results from the international phase 3 AMPLTUDE clinical trial found that adding niraparib to abiraterone…
Results from the DIAmOND clinical trial have shown that adding dual immunotherapy to existing treatments…
Small cell lung cancer (SCLC) accounts for approximately 15% of lung cancers, and most patients…